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Abstract
Recent studies indicate a mutual epidemiological relationship between coronary heart disease (CHD) and periodontitis. Both
diseases are associated with similar risk factors and are characterized by a chronic inflammatory process. In a candidate-
gene association study, we identify an association of a genetic susceptibility locus shared by both diseases. We confirm the
known association of two neighboring linkage disequilibrium regions on human chromosome 9p21.3 with CHD and show
the additional strong association of these loci with the risk of aggressive periodontitis. For the lead SNP of the main
associated linkage disequilibrium region, rs1333048, the odds ratio of the autosomal-recessive mode of inheritance is 1.99
(95% confidence interval 1.33–2.94; P=6.9 610
24) for generalized aggressive periodontitis, and 1.72 (1.06–2.76;
P=2.6610
22) for localized aggressive periodontitis. The two associated linkage disequilibrium regions map to the
sequence of the large antisense noncoding RNA ANRIL, which partly overlaps regulatory and coding sequences of CDKN2A/
CDKN2B. A closely located diabetes-associated variant was independent of the CHD and periodontitis risk haplotypes. Our
study demonstrates that CHD and periodontitis are genetically related by at least one susceptibility locus, which is possibly
involved in ANRIL activity and independent of diabetes associated risk variants within this region. Elucidation of the
interplay of ANRIL transcript variants and their involvement in increased susceptibility to the interactive diseases CHD and
periodontitis promises new insight into the underlying shared pathogenic mechanisms of these complex common diseases.
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Introduction
Coronary Heart Disease (CHD) is the leading cause of death
worldwide [1,2]. It is a systemic disease which is propagated by
several environmental and behavioural risk factors [3–7] with
inflammation as an important additional risk [8]. It has a strong
genetic basis [9], but despite decades of intensive genetic research,
until recently, the sequence variants that confer cardiovascular risk
had remained largely unknown. Periodontitis is a complex chronic
inflammatory disease, resulting in a loss of connective tissue and
bone support of the teeth [10]. It is the major cause of tooth loss in
adults above 40 years, and according to the WHO, affects human
populations worldwide at prevalence rates of up to 10 to 20% for
the most severe forms [11]. Moreover, it is associated with an
increase in premature death in adults [12]. Formal genetic studies
have demonstrated the genetic basis of periodontitis and indicated
that about half of the population variance in chronic periodontitis
can be attributed to genetic factors, with a concordance rate of
0.23–0.38 for monozygotic twins [13], and a heritability of 50%
for dizygotic twins [14]. But hitherto, association studies with
periodontitis have led to controversial results and its inherited
components have remained unexplained [15].
Epidemiological studies demonstrated an association between
the presence of CHD and periodontitis [16,17], which is
dependent on the severity of periodontal disease [18,19]. CHD
is also propagated by risk factors similar to periodontitis. Both
diseases share smoking as a major environmental risk factor and
relate to diabetes mellitus, obesity, and gender [6,7,20–22]. Recent
studies also demonstrated similarities in the spectrum of bacteria in
the oral cavity and in coronary plaques [23,24], and both diseases
are characterized by an imbalanced immune reaction and a
chronic inflammatory process [25,26]. Periodontitis is also
associated with elevated C-reactive protein levels [27], a
phenotype for which common genetic risk factors for periodontitis
and atherosclerosis have been discussed [28]. These findings
indicate a possible mutual genetic basis underlying both diseases.
Recently, four independent genome-wide association studies
(GWAS) reported a strong association of a region of elevated linkage
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upstream of the CDKN2A and CDKN2B genes [29–32]. The first
two studies identified three individual SNPs (rs238206 [29],
P=6.7 610
26; rs10757274 [29], P=3.7 610
26, and rs10757278
[30], P=1.5 610
27) ,w h i c hw e r ei nh i g hL Di nH a p M a p[ 3 3 ]C E U
(r
2$0.86). Two subsequent GWA studies [31,32] identified an
association of rs1333049 (P=1.79 610
214 and P=3.4 610
26,
respectively) which is in strong LD with rs10757278 in HapMap
CEU and which is flanking the proximate border of the LD region
(Figure 1). A subsequent meta-analysis in seven different populations
confirmed the association of this region with CHD [34], making it the
best replicated genetic risk locus of CHD to date. To investigate
whether this locus may also relate to the risk for periodontitis, we
investigated a possible association of this LD region with aggressive
periodontitis (AgP), the most extreme form of periodontal diseases for
which it is assumed that genetic factors play a greater role in the
susceptibility than for chronic periodontitis [15].
Results
In the first stage of the experiment, we selected three SNPs of
this LD region (rs2891168, rs1333042 and rs1333048), and
verified the putative associations of these SNPs with CHD in a
large population of 1,104 early-onset CHD patients (age at disease
onset ,55 years) and 736 healthy ethnically matched controls
(Table 1). All SNPs gave evidence for association with CHD
(Table 2, for genotypes refer to Table S1), with SNP rs2891168
being the marginally most significant (Pmultiplicative=1.1610
26,
OR=1.42 [95% confidence interval 1.23–1.64]). We subsequently
replicated the association signals in a second independent sample
set that comprised the same numbers of CHD patients (age of
disease onset ,65 years) and of healthy ethnically matched
controls as the first sample set. Again, all genotyped SNPs gave
similar evidence for association with CHD, Pmultiplicative=2.5610
25
(OR of 1.33 [95% confidence interval 1.16–1.51]) for the most
significant, SNP rs1333042 (Table 2).
Association of the Chromosome 9p21.3 Locus with
Generalized AgP
After verification of the CHD associations, we genotyped these
SNPs in 159 German periodontitis patients with the most extreme
phenotype of AgP, generalized AgP ($50% bone loss at $7 teeth
below the age of 35), and 736 independent ethnically matched
healthy controls (Table 1). All SNPs were associated with
periodontitis, with a multiplicative OR of 1.42 (95% confidence
interval 1.11–1.81), P=4.8610
23 and 1.42 (1.11–1.81),
P=5.2610
23 for the two most significant SNPs rs1333042 and
rs1333048, respectively (Table S2, Table S3). Next, we adjusted
for the established AgP risk factors smoking, type 2 diabetes, and
the potential confounder gender. Upon adjustment, the effect of
the rare alleles of the analyzed markers remained highly significant
and was similar to that seen in the unadjusted analysis (Table 3).
We considered a full genotypic model as well as a dominant, a
multiplicative, and a recessive model for the rare marker allele in a
logistic regression analysis. Recessive and multiplicative models
yielded P-values of similar magnitude for all three markers, with
SNP rs1333048 showing the strongest association under the
recessive model (P=6.9610
24, OR=1.99 [95% confidence
interval 1.33–2.94]). In line with this, genotypic ORs of SNP
rs1333048 equalled 1.12 (0.70–1.80) for heterozygotes and 2.13
(1.31–3.50) for homozygotes, suggesting an underlying genetic
model somewhere between the recessive and the multiplicative
one. This is supported by the Akaike’s Information Criterion (AIC;
Table S4), which do not differ between the recessive and the
multiplicative model by more than 3.0 for any of the SNPs.
Association of the Chromosome 9p21.3 Locus with
Localized AgP
Wereplicated the associationsin anindependentpopulationof146
German periodontitis patients with the less severe AgP phenotype
localized AgP ($50% bone loss at 2–6 teeth below the age of 35), and
further368ethnicallymatchedhealthycontrols.AllSNPswere found
to be significantly associated at both the multiplicative and the
genotypic level. SNP rs1333048 was again most significant, with a
recessive OR of 1.70 (95% confidence interval 1.06–2.68),
P=2.5 610
22 (Table S2). After adjustment for the covariates
smoking, type 2 diabetes and gender, all SNPs remained significant
in the multiplicative genetic model, but not so under the recessive
model. The smallest P-value was again observed for SNP rs1333048
(Pmultiplicative=5.9 610
23) (Table 3). However, genotypic ORs were
similar, albeit slightly higher than those observed for generalized AgP
(ORhet=1.56 [0.94–2.64], ORhom=2.30 [1.28–4.20]), and AIC
values between the two models differed by less than 3.0 (Table S4),
again suggesting a not completely autosomal-recessive model for the
genetic effect of this SNP.
The minor allele of rs1333048 has a frequency of 54% in the
combined AgP case samples and of 45% in the combined controls
(Table S3). These frequencies correspond to those found in this
LD region by the WTCCC study (55% in cases, 47% in controls)
[31] and by the German myocard infarct study (54% in cases,
48% in controls, [32]).
Association Analysis of the Proximal CHD Associated LD
Region
The analyzed LD region is defined by a region of moderate LD
(average D9 approximately 0.60) stretching at the 59 site [34]
(Figure 1). There, a second region of elevated LD, moderately in
LD with the main CHD-associated LD region, harbours further
CHD associated SNPs [32,34] (Figure 1). Three tagging SNPs
(rs7044859, rs1292136 [recently renamed rs496892], and
rs7865618) were identified to be sufficient to characterize the
main haplotypes of this region [34]. To test these SNPs for possible
associations with AgP, we performed a two step case-control
analysis. If a shared genetic cause for both diseases is assumed,
Author Summary
Coronary heart disease (CHD) and periodontitis are the
most widespread diseases in the Western industrialized
world and pose a substantial health threat to populations
worldwide. CHD is a leading cause for premature death,
and periodontitis is the major cause for tooth loss in adults
over 40 years. Both diseases are associated with similar risk
factors such as smoking, diabetes, and gender, and both
diseases are further characterized by a chronic inflamma-
tory process. In the last year, several genome studies have
identified a region of the human genome near the CDKN2A
and CDKN2B genes as having an influence on CHD. We
show that this genetic region, being the most important
susceptibility locus for CHD to date, is also associated with
a substantial risk increase of aggressive periodontitis. The
associated genetic region maps to a genomic region that
codes for an ‘‘antisense RNA,’’ which partly overlaps
regulatory and coding sequences of genes CDKN2A/
CDKN2B. The interplay between these common inflamma-
tory complex diseases could be partially due to the shared
genetic risk variants of this antisense RNA.
Shared Risk Variants of Periodontitis and CHD
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consistent in clinical cohorts of related diseases, while SNP
associations secondary to the main associated LD structure are
much less likely to be consistently observed, due to different LD
patterns in different cohorts. As with the GWA studies on CHD, in
our study, the 39 LD region gave stronger association signals than
the second LD region. Among the three tagging SNPs, only SNP
rs496892 was significant in both AgP populations after adjustment.
Here, the OR was 1.36 (95% confidence interval 1.04–1.79),
P=2.4610
22 for generalized AgP, and 1.38 (95% confidence
interval 1.02–1.86), P=3.6610
22 for localized AgP (Table 4,
Table S3) in the multiplicative model.
Statistical evidence of the CHD association signals suggested
that the main associated LD region alone did not fully explain the
association with CHD [34]. To test this, we performed a haplotype
analysis [35] and pooled the two AgP populations to increase
statistical power. The analysis indicated that rs1333048 accounted
for most of the association with periodontitis (data not shown),
similar to the genetic effect observed for the same haplotypic
backgrounds in the CHD populations [34].
Association Analysis with T2D Associated SNP
rs10811661
The analyzed LD region is further defined by a recombination
hot spot 39 to rs1333049. (Figure 1). To our knowledge, there is no
evidence in the literature for an association with CHD distal to
rs1333049 [29–32,34,36]. Three studies demonstrated an associ-
ation of rs10811661 with type 2 diabetes [37–39] (T2D; 8.6 kb
downstream of rs1333049; Figure 1). However, no association of
this variant was observed with coronary heart disease [36].
Because T2D is an established risk factor for periodontitis we
tested the T2D associated SNP rs10811661 for an additional
Figure 1. LD Structure (r
2) of the Chromosome 9p21.3 Locus in HapMap CEU. The tagging SNPs of the CDKN2A/2B genes (1–13) are given to
indicate the extent of these genes on the LD map. They are the only known genes within this genetic region (NCBI build36). Further SNPs are placed
on the LD map: the three tagging SNPs of the adjacent AgP/CHD associated LD region (14–16), the four GWAS lead-SNPs of the main AgP/CHD
associated LD region (18, 21, 22, 24), the three candidate SNPs selected for this study (19, 20, 23), and the T2D associated SNP (26). SNPs which were
genotyped in this study are underlined, the four CHD-associated GWAS lead SNPs and the three CHD associated SNPs of the second LD region are
marked by asterisks. SNP 17 and 25 are included into the figure to describe the distinct borders of the LD region. They are located immediately 59 and
39 to rs4977574 and rs1333049, respectively). All RefSeq genes and transcripts of this region are placed on the physical gene map, which has been
aligned to the LD map and SNP positions below.
doi:10.1371/journal.pgen.1000378.g001
Shared Risk Variants of Periodontitis and CHD
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or after adjustment for smoking, diabetes and gender was detected
(Table 4).
Discussion
In this candidate gene association study we provide evidence for
a shared association of the CHD high-risk locus on chromosome
9p21.3 with AgP. We selected SNPs which were located on the
same LD region as the lead SNPs of previous GWA studies on
CHD, by which they were flanked. We verified the selected SNPs
for their association with CHD prior to the replication in the AgP
populations. For the initial verification panel we used CHD cases
with an age of disease onset ,55 years, a particular young age for
disease onset, for which it is expected that genetic factors make a
particularly high contribution to disease development. The
homozygote OR for the three analyzed SNPs ranged from 1.92
to 2.02 and were, thus, in a range similar to the homozygote ORs
observed in the WTCCC CHD study (OR=2.07). The replication
panel of CHD patients was on average nine years older than the
verification panel. Patient collections of older age at disease onset
are generally considered to have a higher proportion of individuals
who were more strongly exposed to environmental and/or
behavioral risk factors than to genetic ones. In our study, the
decreased homozygote ORs in the replication panel, which ranged
from 1.59 to 1.74 for the three analyzed SNPs, could be due to this
effect, although a simple overestimation of the effect size in the
screening panel is an equally likely cause. The controls were
ethnically matched with the CHD cases but younger in age. This
problem was also encountered earlier by the WTCCC CHD study
(cases ,66 years vs. two controls panels of 49 years and an age
range of 18 to 69 years, respectively). As with the WTCCC study,
we also could not adjust for the CHD specific risk factors as the
necessary information was not available from the blood donors
used as controls. However, the CHD association of this risk LD
region appeared to be remarkably uniform in other replication
studies and showed no evidence of gene-environmental interac-
tions in that the associations did not appear to be modified by the
common CHD risk factors: age gender, smoking history,
hypertension, diabetes, obesity, or variations in LDL-, and
HDL-cholesterol levels [40].
After the verification of the association of the selected SNPs with
CHD, we showed that these variants were also associated with
AgP in two independent populations. The robustness of these
significant findings was supported by the fact that the inclusion of
covariates such as smoking and gender did not notably alter P-
values or effect sizes. In the explorative analysis we used a
population with the most severe phenotype of periodontitis,
generalized AgP. Similar to the early-onset CHD phenotype, this
most severe form is suspected to be determined by genetic risk
factors in particular. In this case panel, we matched the controls
for an age older than the general age of onset of mild forms of
periodontitis (,60 years). We considered this matching as
appropriate to minimize a possible stratification by individuals
with undiagnosed periodontal diseases because less severe forms of
periodontitis are not easily diagnosed at a young age and the
information of the periodontal status of the controls was self-
reported. Because the locus on chromosome 9p21.3 is associated
with CHD, it could have an effect on survival. Hence, older
controls may represent ‘‘survivors’’ and do not comprise the
complete gene pool of the population. This could cause
stratification. To assess this problem, we matched the controls in
the replication panel for the age of the AgP cases to better mirror
the gene pool of the average population. The independence of the
association signals from the age of the controls in the replication
further confirmed the robustness of the shared association of this
locus in CHD and AgP. This robustness of the findings which
indicate a shared susceptibility locus for CHD and AgP was also
reflected in the similar frequency difference of the rare alleles in
both the WTCCC study on CHD and the presented study on
AgP, which both differed by approximately 10% between cases
and controls. The observed association of a shared susceptibility
Table 1. Baseline Characteristics of the Study Populations.
Verification Replication Verification Replication
CHD cases Controls CHD cases Controls Generalized AgP Controls Localized AgP Controls
Subject characteristic
Individuals, n 1,097 736 1,104 736 151 736 137 368
Men (%) 918 (83.7) 222 (30.2) 829 (75.1) 366 (49.7) 53 (35.1) 385 (52.3) 54 (39.4) 184 (50.0)
Women (%) 179 (16.3) 510 (69.3) 275 (24.9) 370 (50.3) 96 (63.6) 351 (47.7) 83 (61) 184 (50.0)
Mean age (SD) at first diagnosis 48 (5.7) - 57 (6.4) - 30 (5.6) - 29 (5.1) -
Mean (SD) age at examination 57 (5.9) 42 (12.7) 65 (6.1) 46 (13.1) 38 (6.6) 63 (7.4) 37 (7.0) 37 (9.6)
Study information
Recruitment period 2003–05 2003–06 2003–05 2003–06 2004–06 2005–06 2004–06 2005–06
Phenotype, n (%)
Affected teeth, n ----1 3 ( 5 . 8 )-4 ( 1 . 4 ) -
Myocardial Infarction 727 (66.3) - 655 (59.3) - 0 32 (4.4) 0 1 (0.3)
Family history CHD 537 (48.6) - 423 (38.3) - No report 113 (15.4) No report 40 (10.9)
AgP risk factor, n (%)
Ever smoked 868 (79.1) - 755 (68.4) - 83 (55.0) 382 (51.9) 59 (43.1) 200 (54.4)
Diabetes mellitus 195 (17.8) - 218 (19.8) - 2 (1.3) 48 (6.5) 1 (0.7) 0
Values are given as mean (standard deviation [SD]) when appropriate). Affection status was based on reported history (except for the number of affected teeth which
was analyzed on the basis of radiographs by the clinicians, smoking was estimated by self-report). CHD – Coroanry Heart Disease, AgP – Aggressive Periodontitis.
doi:10.1371/journal.pgen.1000378.t001
Shared Risk Variants of Periodontitis and CHD
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PLoS Genetics | www.plosgenetics.org 5 February 2009 | Volume 5 | Issue 2 | e1000378locus for AgP and CHD suggests a shared genetic cause for these
diseases which implies a partly overlapping genetic mechanism of
disease development. However, it is likely that by hitherto
unknown mechanisms, one disease may also have a direct causal
influence on the susceptibility of the other. The mechanisms of
these interactions await further elucidation. It can also be argued
that some of the epidemiological associations between periodon-
titis and CHD can be explained by shared socioeconomic risk
factors which promote the development of both diseases. If so, AgP
cases would be likely to develop future CHD. Likewise, CHD case
populations would comprise significant proportions of unpheno-
typed periodontitis patients. Whereas this might be true for the
common forms of chronic periodontitis and late onset CHD, it is
unlikely for the severe early onset forms of these diseases. To
further limit the potential cause of stratification, we employed
cases with a particularly young age and a strong phenotype for
both diseases, where the effect of environmental or behavioural
factors are limited, and who are considered to carry a strong
genetic burden. To add evidence to a genetic rather than a
socioeconomical association, the statistical data of the risk LD
regions did not appear to be modified by the common
environmental and behavioural risk factors known to increase
the susceptibility for CHD and/or periodontitis.
Although small compared to other association studies on
complex diseases, the presented AgP population represents, to
date and to our knowledge, the largest population of this
phenotype worldwide. It could be argued that studies with such
small sample sizes are prone to increased type I and type II errors.
However, for the explorative study we had a statistical power of
.90% to detect the observed genetic effects but a confirmation of
the described association in further and larger AgP populations
would be desirable.
The nearest described protein coding genes within the region of
our associated SNPs are the genes CDKN2A/2B, which are located
.104 kb in 59 direction and are not in LD with the analyzed
haplotypes (r
2,0.15). They encode inhibitors of the genes CDK4/
CDK6 and are believed to play critical roles in cell proliferation
and tumor suppression. A third gene, MTAP, is located further
upstream in close proximity. Many studies also reported MTAP
function as a tumor suppressor gene and described an inverse
correlation between MTAP protein levels and the progression of
various tumors [41–45]. Interestingly, the association of MTAP
activity and interferon sensitivity has been reported [41,44,46],
indicating a possible role in immune response. Both analyzed risk
LD regions do not map to a sequence of these genes, but are
embedded in the large antisense noncoding RNA (ncRNA) ANRIL
[47], belonging to a class of genes thought to be part of the
regulatory repertoire of the transcriptome [48]. This gene overlaps
CDKN2B but does not share any coding nucleotide sequences.
Interestingly, mRNA AF109294, which is thought to encode a
hypothetical MTAP fusion protein mRNA, also partially overlaps
ANRIL, sharing two exons. Expression data suggested a coordi-
nated transcriptional regulation of ANRIL, CDKN2A and CDKN2B
[47], and expression in tissues involved in atherosclerosis, like
vascular endothelial cells, macrophages, and coronary smooth
muscle cells, had been shown [40]. The function and mechanism
of action for this ncRNA is yet unknown. Full length deletion of
ANRIL was associated with cutaneous melanoma [47] and the
CHD and AgP high-risk haplotype, overlapping exons 13–19 of
ANRIL, is associated with diseases that also share a phenotype of
abnormal cell proliferation. A shared function of the neighbouring
genes CDKN2A/2B and MTAP is the regulation of cell prolifer-
ation/tumor suppression. It is tentative to speculate a mechanistic
link between the overlapping disease phenotypes of impaired cell
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ncRNA ANRIL. The interplay of these genes in the tissue specific
regulation of cell proliferation could be mediated by this antisense
RNA. It is intriguing that the CHD and AgP phenotypes share
high-risk LD regions, whereas T2D has apparently independent
risk variants within this region. Elucidation of the interplay of
ANRIL transcript variants and their involvement in increased
susceptibility to interactive diseases like CHD and periodontitis
promises new insight into the underlying partially shared
pathogenic mechanisms, and will open up new avenues in the
understanding of the development of these complex common
diseases.
Methods
Study Populations
The CHD patients comprised a population-representative
collection of unrelated Germans (Table 1). They were recruited
from Schleswig-Holstein, the northernmost region in Germany,
through the population-based PopGen biobank [49]. In the
recruitment area, all coronary angiograms of any of the five
cardiac catheterization laboratories were screened. Study subjects
were required to have coronary catheterization demonstrating
significant CHD (at least a 70% stenosis in one major epicardial
coronary vessel). 1,104 cases had a diagnosed disease onset
,55 years, of whom a subset of 596 individuals had suffered a
myocardial infarction. The majority (90.3%) had a history of
severe CHD and had undergone a coronary revascularization
procedure (percutaneous coronary intervention or coronary artery
bypass grafting). The controls were obtained from the Blood
Service of the University Hospital Schleswig-Holstein. Information
about the age and gender was available. Written informed consent
was obtained from all participants and the recruitment and the
experimental protocols were approved by the institutional ethics
review board and data protection authorities.
The AgP patients were recruited from througout Germany.
Only patients of German ethnicity were included, determined by
the location of both parental birthplaces. Prior to the study, the
genetic sub-structure of the German population had been assessed
[50], indicating only negligible sub-structures and therefore
allowing a joint analysis of all individuals. A further inclusion
criterion was age at diagnosis #35 years. A set of full-mouth
dental radiographs was available for confirmative periodontal
bone scoring, $2 teeth with $50% periodontal bone loss was
defined as inclusion criterion. The sub-phenotype of localized AgP
was characterized by $50% bone loss at 2–6 teeth; the sub-
phenotpye generalized AgP was characterized by $50% bone loss
at $7 teeth. The ethnically matched controls used for generalized
AgP association study were randomly identified on the basis of the
local population registry and the controls used for localized AgP
were obtained from the Blood Service of the University Hospital
Schleswig-Holstein. All controls underwent an additional physical
examination at the PopGen facilities to obtain information on
general health status. Information on the oral health status and
physical risk factors (e.g. smoking, diabetes) was obtained from
questionnaires completed during medical consultation. Addition-
ally, a clinical checkup was subsequently performed. All controls
self reported to be free of periodontitis.
Genotyping
Genomic DNA was extracted from blood samples (Invisorb
Blood Universal Kit, Invitek, Berlin, Germany) and amplified by
whole genome amplification (GenomiPhi, Amersham, Uppsala,
Sweden). Genotyping was performed using the SNPlex and
TaqMan GenotypingSystem (Applied Biosystems, Foster City,
CA, USA) on an automated platform, employing TECAN
Freedom EVO and 96-well and 384-well TEMO liquid handling
robots (TECAN, Ma ¨nnedorf, Switzerland). Genotypes were
generated by automatic calling using the Genemapper 4.0
software (Applied Biosystems) with the following settings: sigma
separation .6, angle separation for 2 cluster SNPs ,1.2 radians,
median cluster intensity .2.2 logs. Genotypes were additionally
reviewed manually and call rates .95% in each sample set were
required.
Statistical Analysis
Power calculations were performed using PS Power and Sample
Size Calculations [51]. Markers were tested for deviations from
Hardy-Weinberg equilibrium in controls before inclusion in the
analysis (http://ihg2.helmholtz-muenchen.de/cgi-bin/hw/hwa2.
pl, a=0.05). Single-marker case-control analysis was performed
using Haploview v4.0 [52], PLINK v2.049 [53], and FamHap
[35]. LD measures were plotted with the GOLD program [54].
We assessed the significance of associations with or between single-
locus genotypes using x
2 and Fisher’s exact tests for 262 and 263
contingency tables where applicable. Logistic regression analysis
was performed in R v2.7.2 [55]. Significance was assessed by a
Wald test and by a likelihood-ratio test.
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